Minimising Unnecessary Mastectomies in a Predominantly Chinese Community

Table 3

List of patients with posttreatment events.

Presentation	Treatment	Time to local recurrence	Time to distant recurrence	Treatment for recurrence	Comments/outcome
T3N1	Neoadjuvant chemotherapy, BCT, RT	Four months	Nil	Mastectomy	Disease-free at 57 months
T3N2	Neoadjuvant chemotherapy, mastectomy, RT	Nil	35 months, visceral, bony	Chemotherapy	Succumbed at 42 months
T2N2	BCT, adjuvant chemotherapy, RT	33 months	33 months, visceral	Declined treatment	Lost to follow-up
T3N3	Disease progression during neoadjuvant chemotherapy, mastectomy, RT	8 months	15 months, CNS	Declined further chemotherapy, VP shunt	Succumbed at 20 months
T3N1	Neoadjuvant chemotherapy, BCT, RT	Nil	9 months, CNS	Declined further chemotherapy	Died 13 months after surgery
T3N0	Neoadjuvant chemotherapy, BCT, RT	Nil	12 months, CNS	Chemotherapy	Died 19 months after surgery

BCT: breast conservation treatment.
RT: radiotherapy.
CNS: recurrence in the central nervous system.